Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 2 |
2007 | 1 |
2008 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance.
Mol Cell Biol. 2008 Oct;28(20):6496-509. doi: 10.1128/MCB.00477-08. Epub 2008 Aug 11.
Mol Cell Biol. 2008.
PMID: 18694961
Free PMC article.
Multiple joint effusions associated with high-dose imatinib therapy in a patient with chronic myelogenous leukaemia.
Moore JC, Dennehey CF, Anavim A, Kong KM, Tiong Ong S.
Moore JC, et al.
Eur J Haematol. 2006 May;76(5):444-6. doi: 10.1111/j.1600-0609.2006.00649.x. Epub 2006 Mar 17.
Eur J Haematol. 2006.
PMID: 16548915
Item in Clipboard
A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation.
Prabhu S, Saadat D, Zhang M, Halbur L, Fruehauf JP, Ong ST.
Prabhu S, et al.
Oncogene. 2007 Feb 22;26(8):1188-200. doi: 10.1038/sj.onc.1209901. Epub 2006 Aug 28.
Oncogene. 2007.
PMID: 16936779
Free PMC article.
Item in Clipboard
Cite
Cite